BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
92.80
-0.87 (-0.93%)
At close: Aug 10, 2026, 4:00 PM EDT
93.37
+0.57 (0.61%)
Pre-market: Aug 11, 2026, 8:21 AM EDT

BioNTech SE Revenue

BioNTech SE had revenue of 145.80M EUR in the quarter ending June 30, 2026, a decrease of -56.99%. This brings the company's revenue in the last twelve months to 2.43B, down -0.35% year-over-year. In the year 2025, BioNTech SE had annual revenue of 3.05B with 5.63% growth.

Revenue (ttm)
2.43B EUR
Revenue Growth
-0.35%
P/S Ratio
7.70
Revenue / Employee
310,785 EUR
Employees
7,807
Market Cap
23.31B USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20253.05B162.80M5.63%
Dec 31, 20242.89B-1.03B-26.31%
Dec 31, 20233.92B-13.39B-77.33%
Dec 31, 202217.31B-1.67B-8.78%
Dec 31, 202118.98B18.49B3,834.63%
Dec 31, 2020482.30M373.70M344.11%
Dec 31, 2019108.60M-18.98M-14.87%
Dec 31, 2018127.58M65.98M107.11%
Dec 31, 201761.60M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.